RECK anticorps (AA 801-900) (Biotin)
-
- Antigène Voir toutes RECK Anticorps
- RECK (Reversion-Inducing-Cysteine-Rich Protein with Kazal Motifs (RECK))
-
Épitope
- AA 801-900
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp RECK est conjugé à/à la Biotin
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro))
- Homologie
- Human,Mouse,Rat,Dog,Cow,Pig,Rabbit
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human RECK
- Isotype
- IgG
- Top Product
- Discover our top product RECK Anticorps primaire
-
-
- Indications d'application
-
WB 1:300-5000
IHC-F 1:100-500 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C for 12 months.
- Date de péremption
- 12 months
-
- Antigène
- RECK (Reversion-Inducing-Cysteine-Rich Protein with Kazal Motifs (RECK))
- Autre désignation
- RECK (RECK Produits)
- Synonymes
- anticorps ST15, anticorps St15, anticorps mRECK, anticorps reversion inducing cysteine rich protein with kazal motifs, anticorps reversion-inducing-cysteine-rich protein with kazal motifs, anticorps RECK, anticorps Reck
- Sujet
-
Synonyms: ST15, Reversion-inducing cysteine-rich protein with Kazal motifs, hRECK, Suppressor of tumorigenicity 15 protein, RECK
Background: Negatively regulates matrix metalloproteinase-9 (MMP-9) by suppressing MMP-9 secretion and by direct inhibition of its enzymatic activity. RECK down-regulation by oncogenic signals may facilitate tumor invasion and metastasis. Appears to also regulate MMP-2 and MT1-MMP, which are involved in cancer progression.
- ID gène
- 8434
- UniProt
- O95980
-